ACOU085

· Acousia Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACOU085, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin [Phase 2]